Simplex Trading’s Milestone Pharmaceuticals MIST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$34K Buy
+28,600
New +$50.1K ﹤0.01% 6260
2025
Q4
Sell
-71,800
Closed -$143K 9461
2025
Q3
$143K Sell
71,800
-55,000
-43% -$96.7K ﹤0.01% 5337
2025
Q2
$245K Buy
126,800
+79,000
+165% +$105K ﹤0.01% 4286
2025
Q1
$38K Buy
+47,800
New +$95K ﹤0.01% 6051
2024
Q1
Sell
-1,500
Closed -$2K 9442
2023
Q4
$2K Hold
1,500
﹤0.01% 8302
2023
Q3
$4K Buy
+1,500
New +$4.66K ﹤0.01% 7784
2023
Q2
Sell
-1,200
Closed -$4K 9551
2023
Q1
$4K Sell
1,200
-12,900
-91% -$47.2K ﹤0.01% 8192
2022
Q4
$55K Sell
14,100
-124,600
-90% -$656K ﹤0.01% 5757
2022
Q3
$1.27M Buy
138,700
+137,800
+15,311% +$1.05M ﹤0.01% 2375
2022
Q2
$5K Sell
900
-107,500
-99% -$661K ﹤0.01% 8841
2022
Q1
$695K Buy
108,400
+107,600
+13,450% +$672K ﹤0.01% 3410
2021
Q4
$5K Sell
800
-114,900
-99% -$688K ﹤0.01% 9534
2021
Q3
$650K Hold
115,700
﹤0.01% 3703
2021
Q2
$636K Buy
115,700
+114,401
+8,807% +$649K ﹤0.01% 3789
2021
Q1
$752K Buy
1,299
+1,267
+3,959% +$9.27K ﹤0.01% 2789
2020
Q4
$21K Buy
+32
New +$214 ﹤0.01% 6943

Other funds holding MIST

Simplex Trading's MIST Position: Q1 2026 in Review

Simplex Trading opened a new position in Milestone Pharmaceuticals (MIST) in Q1 2026: 149,291 shares worth $178K. The stake represents ﹤0.01% of the portfolio and ranks #4432 among its holdings. This is a return to the name: Simplex Trading previously reported a position in MIST as recently as Q3 2025.

Simplex Trading first reported a position in MIST in Q3 2020 and has held it in 10 quarters since. 85 funds tracked by Wall St. Rank hold MIST as of Q1 2026.

  • Simplex Trading held 149,291 shares of Milestone Pharmaceuticals worth $178K as of Q1 2026.
  • Milestone Pharmaceuticals was a new Simplex Trading position in Q1 2026.
  • Milestone Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #4432 holding.
  • Simplex Trading first reported a position in Milestone Pharmaceuticals in Q3 2020 and has held it in 10 quarters since.
  • 85 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.